Diferencia entre revisiones de «Sjögren syndrome»

m (Rossdonaldson1 moved page Sjögren Syndrome to Sjögren syndrome over redirect)
 
(No se muestran 2 ediciones intermedias de 2 usuarios)
Línea 23: Línea 23:
*Respiratory
*Respiratory
**Pleuritis
**Pleuritis
**Interstitial lung disease  
**[[Interstitial lung disease]]
**Obstructive lung disease
**Obstructive lung disease
**[[Pulmonary hypertension]]
**[[Pulmonary hypertension]]
Línea 43: Línea 43:
*Gastrointestinal
*Gastrointestinal
**Primary biliary cirrhosis
**Primary biliary cirrhosis
**celiac sprue
**[[Celiac sprue]]
 


==Differential Diagnosis==
==Differential Diagnosis==
*Sicca complex due to other autoimmune diseases  
*Sicca complex due to other autoimmune diseases  
**[[Sarcoidosis]]
**[[Sarcoidosis]]
**[[IgG4 related disease]]
**[[Rheumatoid arthritis]]
**[[Rheumatoid arthritis]]
**[[SLE]]
**[[SLE]]
Línea 57: Línea 57:
**[[Mumps]]
**[[Mumps]]
**Seasonal allergies
**Seasonal allergies
**Cigarette smoke irritation  
**Cigarette smoke irritation


==Evaluation==
==Evaluation==
Línea 79: Línea 79:
**Good oral hygiene
**Good oral hygiene
**Pylocarpine or Cevimeline for severe xerostomia (parasympathetic and muscarinic agonists)
**Pylocarpine or Cevimeline for severe xerostomia (parasympathetic and muscarinic agonists)
*Hydroxychloroquine  for Sjögren's associated arthritis
*[[Hydroxychloroquine]] for Sjögren's associated arthritis
*[[Prednisone]] or other immunosuppressants (cyclophosphamide or azathioprine for severe systemic symptoms
*[[Prednisone]] or other immunosuppressants ([[cyclophosphamide]] or [[azathioprine]]) for severe systemic symptoms
*AVOID atropine and decongestants (decrease salivary secretions)
*AVOID [[atropine]] and decongestants (decrease salivary secretions)


==Disposition==
==Disposition==

Revisión actual - 02:49 17 ago 2022

Background

  • Systemic autoimmune disorder
  • Lymphocytic infiltration of exocrine glands
  • Can occur in isolation or with other autoimmune diseases (e.g. rheumatoid arthritis, SLE, etc.)
  • Female:male ratio of 9:1
  • 10-40 fold increased risk of lymphoma in SS patients.

Clinical Features

Differential Diagnosis

Evaluation

Emergent

  • Not generally an ED diagnosis
  • Evaluate for emergent complications
  • Thorough physical exam to evaluate for purpura (poor prognosis in primary SS)

Non-Emergent

  • Rheumatoid factor is found in 70% of patients
  • Anti-SS-A/Ro, and SS-B/La antibodies are part of diagnostic criteria
  • Elevated ESR
  • Hypergammaglobulinemia


Management

  • Manage emergent complications
  • Ocular
    • Topical ocular cyclosporine, preservative-free artificial tears, lubricating ointments
  • Oral
    • Frequent sips of water, chewing gum, or hard candies
    • Good oral hygiene
    • Pylocarpine or Cevimeline for severe xerostomia (parasympathetic and muscarinic agonists)
  • Hydroxychloroquine for Sjögren's associated arthritis
  • Prednisone or other immunosuppressants (cyclophosphamide or azathioprine) for severe systemic symptoms
  • AVOID atropine and decongestants (decrease salivary secretions)

Disposition

See Also

External Links

References